{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:48:53Z","timestamp":1787791733462,"version":"build-2784847793"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020097","name":"Foundation for Opioid Response Efforts","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022431","name":"Governor's Office of Crime Prevention and Policy","doi-asserted-by":"publisher","award":["PIGF-2025-0007"],"award-info":[{"award-number":["PIGF-2025-0007"]}],"id":[{"id":"10.13039\/100022431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022431","name":"Governor's Office of Crime Prevention and Policy","doi-asserted-by":"publisher","award":["-0009"],"award-info":[{"award-number":["-0009"]}],"id":[{"id":"10.13039\/100022431","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.drugalcdep.2025.112950","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:04:29Z","timestamp":1761696269000},"page":"112950","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Bridging the gap: Post-release outcome evaluation of the first jail-based telemedicine buprenorphine program"],"prefix":"10.1016","volume":"277","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4194-0181","authenticated-orcid":false,"given":"Annabelle M.","family":"Belcher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Welsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Fitzsimons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Dalverny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Lasher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1796-7117","authenticated-orcid":false,"given":"Kelly","family":"Coble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron D.","family":"Greenblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Blue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Weintraub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112950_bib1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/1475-6773.12686","article-title":"Geographic disparities in availability of opioid use disorder treatment for medicaid enrollees","volume":"53","author":"Abraham","year":"2018","journal-title":"Health Serv. Res"},{"key":"10.1016\/j.drugalcdep.2025.112950_bib2","unstructured":"admlappa. 2023 State of the States. LAPPA. December 5, 2023. Accessed September 12, 2025. \u3008https:\/\/legislativeanalysis.org\/2023-state-of-the-states\/\u3009"},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112950_bib3","first-page":"83","article-title":"Death after jail release","volume":"23","author":"Alex","year":"2017","journal-title":"J. Correct. Health Care J. Natl. Comm. Correct. Health Care"},{"key":"10.1016\/j.drugalcdep.2025.112950_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.703685","article-title":"Buprenorphine induction in a rural Maryland detention center during COVID-19: implementation and preliminary outcomes of a novel telemedicine treatment program for incarcerated individuals with opioid use disorder","volume":"12","author":"Belcher","year":"2021","journal-title":"Front. Psychiatry"},{"issue":"9","key":"10.1016\/j.drugalcdep.2025.112950_bib5","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-159-9-201311050-00005","article-title":"Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009","volume":"159","author":"Binswanger","year":"2013","journal-title":"Ann. Intern Med"},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112950_bib6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1056\/NEJMsa064115","article-title":"Release from prison \u2014 a high risk of death for former inmates","volume":"356","author":"Binswanger","year":"2007","journal-title":"N. Engl. J. Med"},{"issue":"10438","key":"10.1016\/j.drugalcdep.2025.112950_bib7","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0140-6736(24)00344-1","volume":"403","author":"Borschmann","year":"2024","journal-title":"Lancet Lond. Engl."},{"issue":"10438","key":"10.1016\/j.drugalcdep.2025.112950_bib8","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0140-6736(24)00344-1","volume":"403","author":"Borschmann","year":"2024","journal-title":"Lancet Lond. Engl."},{"issue":"6","key":"10.1016\/j.drugalcdep.2025.112950_bib9","doi-asserted-by":"crossref","first-page":"328","DOI":"10.5055\/jom.2007.0021","article-title":"Arrested on heroin: a national opportunity","volume":"3","author":"Boutwell","year":"2007","journal-title":"J. Opioid Manag."},{"issue":"8","key":"10.1016\/j.drugalcdep.2025.112950_bib10","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.cpr.2013.07.007","article-title":"Drop-out from addiction treatment: a systematic review of risk factors","volume":"33","author":"Brorson","year":"2013","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.drugalcdep.2025.112950_bib11","article-title":"Clinician identified barriers to treatment for individuals in Appalachia with opioid use disorder following release from prison: a social ecological approach","volume":"13","author":"Bunting","year":"2018","journal-title":"Addict. Sci. Clin. Pr."},{"key":"10.1016\/j.drugalcdep.2025.112950_bib12","unstructured":"CMS). Telehealth | Medicaid. Accessed September 15, 2025. \u3008https:\/\/www.medicaid.gov\/medicaid\/benefits\/telehealth\u3009"},{"issue":"8","key":"10.1016\/j.drugalcdep.2025.112950_bib13","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/add.12536","article-title":"The impact of opioid substitution therapy on mortality post-release from prison: retrospective data linkage study","volume":"109","author":"Degenhardt","year":"2014","journal-title":"Addict. Abingdon Engl."},{"key":"10.1016\/j.drugalcdep.2025.112950_bib14","doi-asserted-by":"crossref","unstructured":"Donelan C.J., Hayes E., Potee R.A., Schwartz L., Evans E.A. COVID-19 and treating incarcerated populations for opioid use disorder. J Subst Abuse Treat. Published online December 2, 2020:108216. doi:10.1016\/j.jsat.2020.108216","DOI":"10.1016\/j.jsat.2020.108216"},{"key":"10.1016\/j.drugalcdep.2025.112950_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108161","article-title":"Adaptations to jail-based buprenorphine treatment during the COVID-19 pandemic","volume":"121","author":"Duncan","year":"2021","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.drugalcdep.2025.112950_bib16","doi-asserted-by":"crossref","unstructured":"Evans E.A., Wilson D., Friedmann P.D. Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder. Drug Alcohol Depend. Published online January 18, 2022:109254. doi:10.1016\/j.drugalcdep.2021.109254","DOI":"10.1016\/j.drugalcdep.2021.109254"},{"key":"10.1016\/j.drugalcdep.2025.112950_bib17","unstructured":"Five Things About Substance Use Interventions | National Institute of Justice. Accessed September 12, 2025. \u3008https:\/\/nij.ojp.gov\/topics\/articles\/five-things-about-substance-use-interventions\u3009"},{"issue":"9","key":"10.1016\/j.drugalcdep.2025.112950_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.34704","article-title":"Factors associated with the availability of medications for opioid use disorder in US jails","volume":"7","author":"Flanagan Balawajder","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.drugalcdep.2025.112950_bib19","unstructured":"FORE Foundation. Expanding Access to Opioid Use Disorder Treatment Before, During, and After Incarceration: Opportunities for Policy and Practice. November 23, 2020. Accessed December 15, 2022. \u3008https:\/\/forefdn.org\/expanding-access-to-oud-treatment-before-during-and-after-incarceration-opportunities-for-policy-and-practice\/\u3009"},{"issue":"10","key":"10.1016\/j.drugalcdep.2025.112950_bib20","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMsa2415987","article-title":"Medications for opioid use disorder in county jails - outcomes after release","volume":"393","author":"Friedmann","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.drugalcdep.2025.112950_bib21","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1360-0443.2008.002238.x","article-title":"A randomized clinical trial of methadone maintenance for prisoners: findings at 6 months post-release","volume":"103","author":"Gordon","year":"2008","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.drugalcdep.2025.112950_bib22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/jamapsychiatry.2017.4614","article-title":"Postincarceration Fatal overdoses after implementing medications for addiction treatment in a statewide correctional system","volume":"75","author":"Green","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"6","key":"10.1016\/j.drugalcdep.2025.112950_bib23","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.6373","article-title":"Characteristics of US counties with high opioid overdose mortality and low capacity to deliver medications for opioid use disorder","volume":"2","author":"Haffajee","year":"2019","journal-title":"JAMA Netw. Open"},{"issue":"3","key":"10.1016\/j.drugalcdep.2025.112950_bib24","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3122\/jabfm.2022.03.210377","article-title":"Patient and clinician perspectives on two telemedicine approaches for treating patients with mental health disorders in underserved areas","volume":"35","author":"Hall","year":"2022","journal-title":"J. Am. Board Fam. Med JABFM"},{"issue":"3","key":"10.1016\/j.drugalcdep.2025.112950_bib25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/tmj.2020.0536","article-title":"The role of telemedicine in rural mental health care around the globe","volume":"28","author":"Hand","year":"2022","journal-title":"Telemed. J. EHealth J. Am. Telemed. Assoc."},{"key":"10.1016\/j.drugalcdep.2025.112950_bib26","doi-asserted-by":"crossref","unstructured":"Hedegaard H., Mini\u00f1o A.M., Warner M. Urban\u2013Rural Differences in Drug Overdose Death Rates, by Sex, Age, and Type of Drugs Involved, 2017. Center for Disease Control and Prevention; 2019. Accessed April 3, 2020. \u3008https:\/\/stacks.cdc.gov\/view\/cdc\/80469\u3009","DOI":"10.15620\/cdc:102891"},{"key":"10.1016\/j.drugalcdep.2025.112950_bib27","unstructured":"How to Help Those with Opioid Use Disorder in Jails & Prisons. Accessed September 12, 2025. \u3008https:\/\/www.psychiatry.org:443\/news-room\/apa-blogs\/opioid-use-disorder-treatment-in-prisons\u3009"},{"key":"10.1016\/j.drugalcdep.2025.112950_bib28","unstructured":"Jail-Based MAT \u2013 National Commission on Correctional Health Care. Accessed September 12, 2025. \u3008https:\/\/ncchc.org\/jail-based-mat\/\u3009"},{"key":"10.1016\/j.drugalcdep.2025.112950_bib29","unstructured":"Justice Community Overdose Innovation Network (JCOIN) | NIH HEAL Initiative. August 18, 2019. Accessed September 12, 2025. \u3008https:\/\/heal.nih.gov\/research\/research-to-practice\/jcoin\u3009"},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112950_bib30","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.2105\/AJPH.2013.301709","article-title":"Understanding the rural\u2013urban differences in nonmedical prescription opioid use and abuse in the United States","volume":"104","author":"Keyes","year":"2014","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2025.112950_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.109081","article-title":"Robustness of estimated access to opioid use disorder treatment providers in rural vs. urban areas of the United States","volume":"228","author":"Kiang","year":"2021","journal-title":"Drug Alcohol Depend."},{"issue":"12","key":"10.1016\/j.drugalcdep.2025.112950_bib32","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1377\/hlthaff.2017.0890","article-title":"Only one in twenty justice-referred adults in specialty treatment for opioid use receive methadone or buprenorphine","volume":"36","author":"Krawczyk","year":"2017","journal-title":"Health Aff. Proj. Hope"},{"key":"10.1016\/j.drugalcdep.2025.112950_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108329","article-title":"Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings","volume":"126","author":"Krawczyk","year":"2021","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.drugalcdep.2025.112950_bib34","doi-asserted-by":"crossref","unstructured":"Lenz C., Song M., Bandara S., et al. Implementation of Jail and Prison-Based Medication Treatment for Opioid Use Disorder Programs: A Narrative Synthesis. Med Care Res Rev MCRR. Published online June 26, 2025:10775587251345018. doi:10.1177\/10775587251345018","DOI":"10.1177\/10775587251345018"},{"key":"10.1016\/j.drugalcdep.2025.112950_bib35","doi-asserted-by":"crossref","unstructured":"Lim S., Cherian T., Katyal M., et al. Association between jail-based methadone or buprenorphine treatment for opioid use disorder and overdose mortality after release from New York City jails 2011-17. Addict Abingdon Engl. Published online October 28, 2022. doi:10.1111\/add.16071","DOI":"10.1111\/add.16071"},{"issue":"3","key":"10.1016\/j.drugalcdep.2025.112950_bib36","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/00952990.2019.1694536","article-title":"A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the United States","volume":"46","author":"Lister","year":"2020","journal-title":"Am. J. Drug Alcohol Abus."},{"issue":"3","key":"10.1016\/j.drugalcdep.2025.112950_bib37","article-title":"Rural and urban differences in treatment on demand for substance use treatment involving medications for opioid use disorder","volume":"41","author":"Lofaro","year":"2025","journal-title":"J. Rural Health J. Am. Rural Health Assoc. Natl. Rural Health Care Assoc."},{"key":"10.1016\/j.drugalcdep.2025.112950_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107858","article-title":"Estimating the impact of wide scale uptake of screening and medications for opioid use disorder in US prisons and jails","volume":"208","author":"Macmadu","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2025.112950_bib39","unstructured":"Maryland Department of Health and Mental Hygiene. Risk of Overdose Death Following Release from Prison or Jail.; 2014. Accessed September 12, 2025. \u3008https:\/\/health.maryland.gov\/vsa\/Documents\/Overdose\/Briefs\/corrections%20brief_V3.pdf\u3009"},{"key":"10.1016\/j.drugalcdep.2025.112950_bib40","series-title":"In: The Cochrane Collaboration, ed. Cochrane Database of Systematic Reviews","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","author":"Mattick","year":"2003"},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112950_bib41","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"issue":"9","key":"10.1016\/j.drugalcdep.2025.112950_bib42","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1111\/j.1360-0443.2010.02990.x","article-title":"Meta-analysis of drug-related deaths soon after release from prison: drug-related deaths after release from prison","volume":"105","author":"Merrall","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2025.112950_bib43","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jsat.2018.12.003","article-title":"Effectiveness of medication assisted treatment for opioid use in prison and jail settings: a meta-analysis and systematic review","volume":"99","author":"Moore","year":"2019","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.drugalcdep.2025.112950_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2025.104805","article-title":"Barriers to accessing medications for opioid use disorder among rural individuals","volume":"140","author":"Morenz","year":"2025","journal-title":"Int J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2025.112950_bib45","series-title":"Medications for Opioid Use Disorder Save Lives","article-title":"Engineering, and Medicine","author":"National Academies of Sciences","year":"2019"},{"key":"10.1016\/j.drugalcdep.2025.112950_bib46","unstructured":"Office of Public Affairs | Justice Department Issues Guidance on Protections for People with Opioid Use Disorder under the Americans with Disabilities Act | United States Department of Justice. April 5, 2022. Accessed September 12, 2025a. \u3008https:\/\/www.justice.gov\/archives\/opa\/pr\/justice-department-issues-guidance-protections-people-opioid-use-disorder-under-americans\u3009"},{"key":"10.1016\/j.drugalcdep.2025.112950_bib47","unstructured":"Products - Vital Statistics Rapid Release - Provisional Drug Overdose Data. January 7, 2025. Accessed February 3, 2025. \u3008https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm\u3009"},{"issue":"9991","key":"10.1016\/j.drugalcdep.2025.112950_bib48","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(14)62338-2","article-title":"Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial","volume":"386","author":"Rich","year":"2015","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.drugalcdep.2025.112950_bib49","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.drugpo.2018.04.011","article-title":"Opioid-related mortality in rural America: geographic heterogeneity and intervention strategies","volume":"57","author":"Rigg","year":"2018","journal-title":"Int J. Drug Policy"},{"issue":"5","key":"10.1016\/j.drugalcdep.2025.112950_bib50","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.drugpo.2014.10.001","article-title":"Urban vs. rural differences in prescription opioid misuse among adults in the United States: informing region specific drug policies and interventions","volume":"26","author":"Rigg","year":"2015","journal-title":"Int J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2025.112950_bib51","doi-asserted-by":"crossref","unstructured":"Rubin R. Using Telemedicine to Treat Opioid Use Disorder in Rural Areas. JAMA. Published online August 28, 2019. doi:10.1001\/jama.2019.12574","DOI":"10.1001\/jama.2019.12574"},{"key":"10.1016\/j.drugalcdep.2025.112950_bib52","unstructured":"Services B on HC, Medicine I of. The Evolution of Telehealth: Where Have We Been and Where Are We Going? In: The Role of Telehealth in an Evolving Health Care Environment: Workshop Summary. National Academies Press (US); 2012. Accessed September 14, 2025. \u3008https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK207141\/\u3009"},{"key":"10.1016\/j.drugalcdep.2025.112950_bib53","article-title":"Psychiatric treatment conducted via telemedicine versus in-person modality in posttraumatic stress disorder, mood disorders, and anxiety disorders: systematic review and meta-analysis","volume":"10","author":"Shaker","year":"2023","journal-title":"JMIR Ment. Health"},{"issue":"9","key":"10.1016\/j.drugalcdep.2025.112950_bib54","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1377\/hlthaff.2025.00339","article-title":"Telemedicine buprenorphine access for incarcerated people: lessons learned from Maryland\u2019s rural jails","volume":"44","author":"Spaderna","year":"2025","journal-title":"Health Aff. Proj. Hope"},{"key":"10.1016\/j.drugalcdep.2025.112950_bib55","unstructured":"State of Maryland Opioid Operational Command Center. Maryland\u2019s Office of Overdose Response - Quarterly Reports. Accessed September 14, 2025b. \u3008https:\/\/stopoverdose.maryland.gov\/oocc-reports\/\u3009"},{"key":"10.1016\/j.drugalcdep.2025.112950_bib56","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA). SAMHSA Statements, 2025November 15, 2024. Accessed September 15, 2025. \u3008https:\/\/www.samhsa.gov\/about\/news-announcements\/statements\/2024\/dea-hhs-extend-telemedicine-flexiblities-through-2025\u3009."},{"issue":"6","key":"10.1016\/j.drugalcdep.2025.112950_bib57","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s11606-022-07812-x","article-title":"Availability of medications for opioid use disorder in U.S. jails","volume":"38","author":"Sufrin","year":"2023","journal-title":"J. Gen. Intern Med"},{"key":"10.1016\/j.drugalcdep.2025.112950_bib58","doi-asserted-by":"crossref","unstructured":"The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update. J Addict Med. 2020;14(2S Suppl 1):1-91. doi:10.1097\/ADM.0000000000000633","DOI":"10.1097\/ADM.0000000000000633"},{"issue":"11","key":"10.1016\/j.drugalcdep.2025.112950_bib59","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11920-017-0844-0","article-title":"The use of telemedicine and mobile technology to promote population health and population management for psychiatric disorders","volume":"19","author":"Turvey","year":"2017","journal-title":"Curr. Psychiatry Rep."},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112950_bib60","first-page":"5","article-title":"Outcomes for patients receiving telemedicine-delivered medication-based treatment for Opioid Use Disorder: a retrospective chart review","volume":"23","author":"Weintraub","year":"2021","journal-title":"Heroin Addict. Relat. Clin. Probl."},{"issue":"8","key":"10.1016\/j.drugalcdep.2025.112950_bib61","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/ajad.12805","article-title":"Expanding access to buprenorphine treatment in rural areas with the use of telemedicine: buprenorphine in rural areas with telemedicine","volume":"27","author":"Weintraub","year":"2018","journal-title":"Am. J. Addict."},{"issue":"8","key":"10.1016\/j.drugalcdep.2025.112950_bib62","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.18487","article-title":"Mobile telemedicine for buprenorphine treatment in rural populations with opioid use disorder","volume":"4","author":"Weintraub","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"12","key":"10.1016\/j.drugalcdep.2025.112950_bib63","first-page":"29","article-title":"Buprenorphine: a (relatively) new treatment for opioid dependence","volume":"2","author":"Welsh","year":"2005","journal-title":"Psychiatry Edgmont Pa Town"},{"issue":"9","key":"10.1016\/j.drugalcdep.2025.112950_bib64","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.mayocp.2018.07.001","article-title":"Telemedicine\u2019s role in addressing the opioid epidemic","volume":"93","author":"Yang","year":"2018","journal-title":"Mayo Clin. Proc."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687162500403X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037687162500403X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T22:58:11Z","timestamp":1786143491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037687162500403X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":64,"alternative-id":["S037687162500403X"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2025.112950","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bridging the gap: Post-release outcome evaluation of the first jail-based telemedicine buprenorphine program","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2025.112950","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112950"}}